SANTA CLARA, Calif., April 29, 2025--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...
Hosted on MSN
Prehospital ECG linked to lower cardiac mortality
Studies show that performing 12-lead ECGs before hospital arrival improves acute coronary syndrome care, reducing mortality and enabling faster interventions. Detecting ischemia early can identify ...
HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
These are the most basic ECG devices. They are generally used for monitoring the heart, checking for arrhythmias, etc. Nowadays, the portable and wearable health monitoring devices also include ...
HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, ...
7d
HeartBeam (NASDAQ: BEAT) Closes $10M Public Offering to Advance Cardiac Technology Commercialization
HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common ...
HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its collaboration with Mount Sinai aimed at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results